GeneDx (WGS) – Investment Analysts’ Recent Ratings Updates
GeneDx (NASDAQ: WGS) has recently received a number of price target changes and ratings updates: 10/30/2024 – GeneDx had its price target raised by analysts at The Goldman Sachs Group, Inc. from $54.00 to $70.00. They now have a “neutral” rating on the stock. 10/30/2024 – GeneDx had its price target raised by analysts at […]
12 Nov 16:34 · The Cerbat Gem